{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:54:31Z","timestamp":1784609671531,"version":"3.55.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:00:00Z","timestamp":1730505600000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.braindev.2023.07.002","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T04:00:39Z","timestamp":1689912039000},"page":"579-582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pediatric anti-neutral glycosphingolipid antibodies-positive encephalomyeloradiculoneuropathy presenting with prominent brain demyelination"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6200-2381","authenticated-orcid":false,"given":"Satoru","family":"Ochiai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6384-0205","authenticated-orcid":false,"given":"Itaru","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7712-8481","authenticated-orcid":false,"given":"Tatsuro","family":"Mutoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3373-0029","authenticated-orcid":false,"given":"Yuichi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2023.07.002_b0005","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/WNL.0000000000000015","article-title":"Anti-neutral glycolipid antibodies in encephalomyeloradiculoneuropathy","volume":"82","author":"Shima","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2023.07.002_b0010","doi-asserted-by":"crossref","first-page":"e10198","DOI":"10.1016\/j.heliyon.2022.e10198","article-title":"The first pediatric anti-lactosylceramide antibody-positive encephalomyeloradiculoneuropathy","volume":"8","author":"Sasaki","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.braindev.2023.07.002_b0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.5692\/clinicalneurol.cn-001131","article-title":"A case of acute disseminated encephalomyelitis concomitant with polyneuropathy associated with anti-lactosylceramide antibody (in Japanese)","volume":"58","author":"Hayashi","year":"2018","journal-title":"Rinsho Shinkeigaku (Tokyo)"},{"key":"10.1016\/j.braindev.2023.07.002_b0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1469-8749.1968.tb02923.x","article-title":"Encephalo-myelo-radiculo-neuropathy","volume":"10","author":"Blennow","year":"1968","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2023.07.002_b0025","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fneur.2018.00206","article-title":"A patient with encephalomyeloradiculoneuropathy exhibiting a relapsing-remitting clinical course: correlation of serum and cerebrospinal fluid anti-neutral glycosphingolipids antibodies with clinical relapse","volume":"9","author":"Nanaura","year":"2018","journal-title":"Front Neurol"},{"issue":"9 Suppl 2","key":"10.1016\/j.braindev.2023.07.002_b0030","first-page":"S8","article-title":"Consensus definitions for pediatric MS and other demyelinating disorders in childhood","volume":"87","author":"Tardieu","year":"2016","journal-title":"Neurology"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760423001122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760423001122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:51:48Z","timestamp":1759953108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760423001122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":6,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0387760423001122"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2023.07.002","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric anti-neutral glycosphingolipid antibodies-positive encephalomyeloradiculoneuropathy presenting with prominent brain demyelination","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2023.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V. on behalf of The Japanese Society of Child Neurology. All rights reserved.","name":"copyright","label":"Copyright"}]}}